Klaus Hinterding
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Carbohydrate Chemistry and Synthesis, Sphingolipid Metabolism and Signaling, HER2/EGFR in Cancer Research, Microbial Natural Products and Biosynthesis
Most-Cited Works
- → The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate(2012)302 cited
- → Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator(2013)165 cited
- → Novel Immunomodulator FTY720 Is Phosphorylated in Rats and Humans To Form a Single Stereoisomer. Identification, Chemical Proof, and Biological Characterization of the Biologically Active Species and Its Enantiomer(2005)150 cited
- → Organic Synthesis and Biological Signal Transduction(1998)140 cited
- → A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model(2006)126 cited
- → Regioselective Carbomethoxylation of Chiral Epoxides: A New Route to Enantiomerically Pure β-Hydroxy Esters(1999)71 cited
- → Organische Synthese und biologische Signaltransduktion(1998)53 cited
- → Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors(1998)48 cited
- → Stereoselective synthesis of polyketide fragments using a novel intramolecular Claisen-like condensation/reduction sequence(2001)38 cited
- → Synthesis of Chiral Analoguesof FTY720 and its Phosphate(2003)24 cited